[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Controlled Release Drug Market Report 2017

November 2017 | 116 pages | ID: A4F5493BA1DEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Controlled Release Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Controlled Release Drug for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Controlled Release Drug market competition by top manufacturers/players, with Controlled Release Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Allergan
  • BioAlliance Pharma
  • Collegium Pharmaceutical
  • Controlled Therapeutics
  • Cosmo Pharmaceuticals
  • Egalet
  • Encore Therapeutics
  • Flamel Technologies
  • GlaxoSmithKline
  • iCeutica
  • Novartis
  • Pfizer
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • Pills
  • Capsules
  • Injectable Drug Carriers
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Respiratory disease
  • Digestive Disease
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Controlled Release Drug Market Report 2017

1 CONTROLLED RELEASE DRUG OVERVIEW

1.1 Product Overview and Scope of Controlled Release Drug
1.2 Classification of Controlled Release Drug by Product Category
  1.2.1 Asia-Pacific Controlled Release Drug Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Controlled Release Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Pills
  1.2.4 Capsules
  1.2.5 Injectable Drug Carriers
  1.2.6 Others
1.3 Asia-Pacific Controlled Release Drug Market by Application/End Users
  1.3.1 Asia-Pacific Controlled Release Drug Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Respiratory disease
  1.3.3 Digestive Disease
  1.3.4 Others
1.4 Asia-Pacific Controlled Release Drug Market by Region
  1.4.1 Asia-Pacific Controlled Release Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Controlled Release Drug (2012-2022)
  1.5.1 Asia-Pacific Controlled Release Drug Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Controlled Release Drug Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC CONTROLLED RELEASE DRUG COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Controlled Release Drug Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Controlled Release Drug Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Controlled Release Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Controlled Release Drug (Volume and Value) by Type
  2.2.1 Asia-Pacific Controlled Release Drug Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Controlled Release Drug Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Controlled Release Drug (Volume) by Application
2.4 Asia-Pacific Controlled Release Drug (Volume and Value) by Region
  2.4.1 Asia-Pacific Controlled Release Drug Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Controlled Release Drug Revenue and Market Share by Region (2012-2017)

3 CHINA CONTROLLED RELEASE DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 China Controlled Release Drug Sales and Value (2012-2017)
  3.1.1 China Controlled Release Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Controlled Release Drug Revenue and Growth Rate (2012-2017)
  3.1.3 China Controlled Release Drug Sales Price Trend (2012-2017)
3.2 China Controlled Release Drug Sales Volume and Market Share by Type
3.3 China Controlled Release Drug Sales Volume and Market Share by Application

4 JAPAN CONTROLLED RELEASE DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Controlled Release Drug Sales and Value (2012-2017)
  4.1.1 Japan Controlled Release Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Controlled Release Drug Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Controlled Release Drug Sales Price Trend (2012-2017)
4.2 Japan Controlled Release Drug Sales Volume and Market Share by Type
4.3 Japan Controlled Release Drug Sales Volume and Market Share by Application

5 SOUTH KOREA CONTROLLED RELEASE DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Controlled Release Drug Sales and Value (2012-2017)
  5.1.1 South Korea Controlled Release Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Controlled Release Drug Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Controlled Release Drug Sales Price Trend (2012-2017)
5.2 South Korea Controlled Release Drug Sales Volume and Market Share by Type
5.3 South Korea Controlled Release Drug Sales Volume and Market Share by Application

6 TAIWAN CONTROLLED RELEASE DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Controlled Release Drug Sales and Value (2012-2017)
  6.1.1 Taiwan Controlled Release Drug Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Controlled Release Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Controlled Release Drug Sales Price Trend (2012-2017)
6.2 Taiwan Controlled Release Drug Sales Volume and Market Share by Type
6.3 Taiwan Controlled Release Drug Sales Volume and Market Share by Application

7 INDIA CONTROLLED RELEASE DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 India Controlled Release Drug Sales and Value (2012-2017)
  7.1.1 India Controlled Release Drug Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Controlled Release Drug Revenue and Growth Rate (2012-2017)
  7.1.3 India Controlled Release Drug Sales Price Trend (2012-2017)
7.2 India Controlled Release Drug Sales Volume and Market Share by Type
7.3 India Controlled Release Drug Sales Volume and Market Share by Application

8 SOUTHEAST ASIA CONTROLLED RELEASE DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Controlled Release Drug Sales and Value (2012-2017)
  8.1.1 Southeast Asia Controlled Release Drug Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Controlled Release Drug Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Controlled Release Drug Sales Price Trend (2012-2017)
8.2 Southeast Asia Controlled Release Drug Sales Volume and Market Share by Type
8.3 Southeast Asia Controlled Release Drug Sales Volume and Market Share by Application

9 AUSTRALIA CONTROLLED RELEASE DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Controlled Release Drug Sales and Value (2012-2017)
  9.1.1 Australia Controlled Release Drug Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Controlled Release Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Controlled Release Drug Sales Price Trend (2012-2017)
9.2 Australia Controlled Release Drug Sales Volume and Market Share by Type
9.3 Australia Controlled Release Drug Sales Volume and Market Share by Application

10 ASIA-PACIFIC CONTROLLED RELEASE DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Allergan
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Controlled Release Drug Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Allergan Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 BioAlliance Pharma
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Controlled Release Drug Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 BioAlliance Pharma Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Collegium Pharmaceutical
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Controlled Release Drug Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Collegium Pharmaceutical Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Controlled Therapeutics
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Controlled Release Drug Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Controlled Therapeutics Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Cosmo Pharmaceuticals
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Controlled Release Drug Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Cosmo Pharmaceuticals Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Egalet
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Controlled Release Drug Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Egalet Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Encore Therapeutics
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Controlled Release Drug Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Encore Therapeutics Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Flamel Technologies
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Controlled Release Drug Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Flamel Technologies Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 GlaxoSmithKline
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Controlled Release Drug Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 GlaxoSmithKline Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 iCeutica
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Controlled Release Drug Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 iCeutica Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Novartis
10.12 Pfizer

11 CONTROLLED RELEASE DRUG MANUFACTURING COST ANALYSIS

11.1 Controlled Release Drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Controlled Release Drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Controlled Release Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Controlled Release Drug Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC CONTROLLED RELEASE DRUG MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Controlled Release Drug Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Controlled Release Drug Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Controlled Release Drug Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Controlled Release Drug Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Controlled Release Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Controlled Release Drug Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Controlled Release Drug Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Controlled Release Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Controlled Release Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Controlled Release Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Controlled Release Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Controlled Release Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Controlled Release Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Controlled Release Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Controlled Release Drug Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Controlled Release Drug Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Controlled Release Drug Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Controlled Release Drug Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Controlled Release Drug Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Controlled Release Drug
Figure Asia-Pacific Controlled Release Drug Sales Volume (K Pcs) by Type (2012-2022)
Figure Asia-Pacific Controlled Release Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Pills Product Picture
Figure Capsules Product Picture
Figure Injectable Drug Carriers Product Picture
Figure Others Product Picture
Figure Asia-Pacific Controlled Release Drug Sales (K Pcs) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Controlled Release Drug by Application in 2016
Figure Respiratory disease Examples
Table Key Downstream Customer in Respiratory disease
Figure Digestive Disease Examples
Table Key Downstream Customer in Digestive Disease
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Controlled Release Drug Market Size (Million USD) by Region (2012-2022)
Figure China Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Controlled Release Drug Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Asia-Pacific Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Controlled Release Drug Market Major Players Product Sales Volume (K Pcs)(2012-2017)
Table Asia-Pacific Controlled Release Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Controlled Release Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Controlled Release Drug Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Controlled Release Drug Sales Share by Players/Suppliers
Figure Asia-Pacific Controlled Release Drug Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Controlled Release Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Controlled Release Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Controlled Release Drug Revenue Share by Players
Figure 2017 Asia-Pacific Controlled Release Drug Revenue Share by Players
Table Asia-Pacific Controlled Release Drug Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Controlled Release Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Controlled Release Drug by Type (2012-2017)
Figure Asia-Pacific Controlled Release Drug Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Controlled Release Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Controlled Release Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Controlled Release Drug by Type (2012-2017)
Figure Asia-Pacific Controlled Release Drug Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Controlled Release Drug Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Asia-Pacific Controlled Release Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Controlled Release Drug by Region (2012-2017)
Figure Asia-Pacific Controlled Release Drug Sales Market Share by Region in 2016
Table Asia-Pacific Controlled Release Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Controlled Release Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Controlled Release Drug by Region (2012-2017)
Figure Asia-Pacific Controlled Release Drug Revenue Market Share by Region in 2016
Table Asia-Pacific Controlled Release Drug Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Asia-Pacific Controlled Release Drug Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Controlled Release Drug Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Controlled Release Drug Sales Market Share by Application (2012-2017)
Figure China Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Controlled Release Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table China Controlled Release Drug Sales Volume (K Pcs) by Type (2012-2017)
Table China Controlled Release Drug Sales Volume Market Share by Type (2012-2017)
Figure China Controlled Release Drug Sales Volume Market Share by Type in 2016
Table China Controlled Release Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table China Controlled Release Drug Sales Volume Market Share by Application (2012-2017)
Figure China Controlled Release Drug Sales Volume Market Share by Application in 2016
Figure Japan Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Controlled Release Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Controlled Release Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Controlled Release Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan Controlled Release Drug Sales Volume Market Share by Type in 2016
Table Japan Controlled Release Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Japan Controlled Release Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan Controlled Release Drug Sales Volume Market Share by Application in 2016
Figure South Korea Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure South Korea Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Controlled Release Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table South Korea Controlled Release Drug Sales Volume (K Pcs) by Type (2012-2017)
Table South Korea Controlled Release Drug Sales Volume Market Share by Type (2012-2017)
Figure South Korea Controlled Release Drug Sales Volume Market Share by Type in 2016
Table South Korea Controlled Release Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table South Korea Controlled Release Drug Sales Volume Market Share by Application (2012-2017)
Figure South Korea Controlled Release Drug Sales Volume Market Share by Application in 2016
Figure Taiwan Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Taiwan Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Controlled Release Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Taiwan Controlled Release Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Taiwan Controlled Release Drug Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Controlled Release Drug Sales Volume Market Share by Type in 2016
Table Taiwan Controlled Release Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Taiwan Controlled Release Drug Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Controlled Release Drug Sales Volume Market Share by Application in 2016
Figure India Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Controlled Release Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table India Controlled Release Drug Sales Volume (K Pcs) by Type (2012-2017)
Table India Controlled Release Drug Sales Volume Market Share by Type (2012-2017)
Figure India Controlled Release Drug Sales Volume Market Share by Type in 2016
Table India Controlled Release Drug Sales Volume (K Pcs) by Application (2012-2017)
Table India Controlled Release Drug Sales Volume Market Share by Application (2012-2017)
Figure India Controlled Release Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Controlled Release Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Controlled Release Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Controlled Release Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Controlled Release Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia Controlled Release Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Southeast Asia Controlled Release Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Controlled Release Drug Sales Volume Market Share by Application in 2016
Figure Australia Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Australia Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Controlled Release Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Australia Controlled Release Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Australia Controlled Release Drug Sales Volume Market Share by Type (2012-2017)
Figure Australia Controlled Release Drug Sales Volume Market Share by Type in 2016
Table Australia Controlled Release Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Australia Controlled Release Drug Sales Volume Market Share by Application (2012-2017)
Figure Australia Controlled Release Drug Sales Volume Market Share by Application in 2016
Table Allergan Controlled Release Drug Basic Information List
Table Allergan Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Allergan Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Allergan Controlled Release Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Allergan Controlled Release Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table BioAlliance Pharma Controlled Release Drug Basic Information List
Table BioAlliance Pharma Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure BioAlliance Pharma Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure BioAlliance Pharma Controlled Release Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure BioAlliance Pharma Controlled Release Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Collegium Pharmaceutical Controlled Release Drug Basic Information List
Table Collegium Pharmaceutical Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Collegium Pharmaceutical Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Collegium Pharmaceutical Controlled Release Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Collegium Pharmaceutical Controlled Release Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Controlled Therapeutics Controlled Release Drug Basic Information List
Table Controlled Therapeutics Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Controlled Therapeutics Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Controlled Therapeutics Controlled Release Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Controlled Therapeutics Controlled Release Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Cosmo Pharmaceuticals Controlled Release Drug Basic Information List
Table Cosmo Pharmaceuticals Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cosmo Pharmaceuticals Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Cosmo Pharmaceuticals Controlled Release Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Cosmo Pharmaceuticals Controlled Release Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Egalet Controlled Release Drug Basic Information List
Table Egalet Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Egalet Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egalet Controlled Release Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Egalet Controlled Release Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Encore Therapeutics Controlled Release Drug Basic Information List
Table Encore Therapeutics Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Encore Therapeutics Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Encore Therapeutics Controlled Release Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Encore Therapeutics Controlled Release Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Flamel Technologies Controlled Release Drug Basic Information List
Table Flamel Technologies Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Flamel Technologies Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Flamel Technologies Controlled Release Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Flamel Technologies Controlled Release Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table GlaxoSmithKline Controlled Release Drug Basic Information List
Table GlaxoSmithKline Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Controlled Release Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure GlaxoSmithKline Controlled Release Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table iCeutica Controlled Release Drug Basic Information List
Table iCeutica Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure iCeutica Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure iCeutica Controlled Release Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure iCeutica Controlled Release Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Novartis Controlled Release Drug Basic Information List
Table Pfizer Controlled Release Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Pcs) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Controlled Release Drug
Figure Manufacturing Process Analysis of Controlled Release Drug
Figure Controlled Release Drug Industrial Chain Analysis
Table Raw Materials Sources of Controlled Release Drug Major Manufacturers in 2016
Table Major Buyers of Controlled Release Drug
Table Distributors/Traders List
Figure Asia-Pacific Controlled Release Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Controlled Release Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Controlled Release Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Asia-Pacific Controlled Release Drug Sales Volume (K Pcs) Forecast by Region (2017-2022)
Figure Asia-Pacific Controlled Release Drug Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Controlled Release Drug Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Controlled Release Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Controlled Release Drug Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Controlled Release Drug Revenue Market Share Forecast by Region in 2022
Figure China Controlled Release Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Controlled Release Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Controlled Release Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Controlled Release Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Controlled Release Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure South Korea Controlled Release Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Controlled Release Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Taiwan Controlled Release Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Controlled Release Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Controlled Release Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Controlled Release Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Controlled Release Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Controlled Release Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Australia Controlled Release Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Controlled Release Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure Asia-Pacific Controlled Release Drug Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Controlled Release Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Controlled Release Drug Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Controlled Release Drug Price (USD/Pcs) Forecast by Type (2017-2022)
Table Asia-Pacific Controlled Release Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure Asia-Pacific Controlled Release Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories